Australian life sciences company Medical Ethics announce a £3 million investment in Wales

Welsh Secretary: “Investment is a real vote of confidence in Wales’ growing stature as a hotbed of life sciences expertise".

Dr Meredith Sheil, Technical Director & Co-Founder of Medical Ethics, has developed a world leading pain mitigation and wound healing technology for humans and animals.

Melbourne-based life science research and development company Medical Ethics has announced a direct investment of over £3 million in Wales over the next 3 years, making Cardiff its new base in the northern hemisphere.

Medical Ethics develop products that alleviate pain and minimise suffering associated with wounds and surgical procedures in animals. As a UK hub for life sciences expertise, Wales will provide the company with the ideal base to progress the development of its technology for humans.

Medical Ethics chose to invest in the UK for its expertise in a number of fields required for the commercialisation of the company’s technology. This includes regulatory affairs, manufacturing and clinical studies, tax subsidies and patent box incentives.

Currently Medical Ethics engages 18 independent service providers and consultants across the UK and has plans to expand its headcount. The company will also look to use other UK consultants and service providers as it addresses future regulatory and commercialisation requirements.

Medical Ethics has worked with the Department for International Trade (DIT) for 2 years, receiving advice, grant application assistance and introductions to key UK stakeholders including the Wales Wound Institute in Cardiff and Cardiff University, both of which the company now collaborates with. Without DIT’s support, the company would not have been able to identify these connections and would not have chosen the UK as a location for investment.

Allan Giffard, Managing Director, Medical Ethics said: